Exposure–response Analysis and Simulation of Lenvatinib Safety and Efficacy in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer

Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-018-3687-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Sequential Analysis of Neutrophil-To-Lymphocyte Ratio for Differentiated Thyroid Cancer Patients Treated With Lenvatinib

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2020English

Clinicopathological Features Predict Outcomes in Patients With Radioiodine‐Refractory Differentiated Thyroid Cancer Treated With Sorafenib: A Real‐World Study

Oncologist
Cancer ResearchMedicineOncology
2020English

Pcn5 - Treatments of Radioiodine-Refractory Differentiated Thyroid Cancer in Routine Clinical Practice – A Systematic Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Budget Impact and Incremental Survival Benefit of Using Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in Russia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Administration of Lenvatinib to Patients With Anaplastic Thyroid Cancer

JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
2018English

Cohort Study Exploring the Effect of Lenvatinib on Differentiated Thyroid Cancer

Endocrine Journal
EndocrinologyMetabolismDiabetes
2018English

Differentiated Thyroid Cancer in Patients With Prolactinoma

Turkish Journal of Medical Sciences
Medicine
2016English

Post-Surgical Thyroid Ablation With Low or High Radioiodine Activities Results in Similar Outcomes in Intermediate Risk Differentiated Thyroid Cancer Patients

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2013English

Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies

Cancers
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy